Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours - a Multi-Site Retrospective Cohort Study as Part of the Global Germ-Cell Cancer Group (G3) Consortium
Condition: Testicular Neoplasms Intervention: Other: Review of Health Information Sponsors: Walter and Eliza Hall Institute of Medical Research; Royal Marsden NHS Foundation Trust; Melbourne Health Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials